CRBU
Price:
$1.68
Market Cap:
$152.13M
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, a...[Read more]
Industry
Biotechnology
IPO Date
2021-07-23
Stock Exchange
NASDAQ
Ticker
CRBU
According to Caribou Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.01. This represents a change of -53.22% compared to the average of -2.16 of the last 4 quarters.
The mean historical PE Ratio of Caribou Biosciences, Inc. over the last ten years is -18.37. The current -1.01 PE Ratio has changed 449.69% with respect to the historical average. Over the past ten years (40 quarters), CRBU's PE Ratio was at its highest in in the June 2024 quarter at -0.95. The PE Ratio was at its lowest in in the June 2020 quarter at -60.28.
Average
-18.37
Median
-13.59
Minimum
-41.77
Maximum
-3.84
Discovering the peaks and valleys of Caribou Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.89%
Maximum Annual PE Ratio = -3.84
Minimum Annual Increase = -71.74%
Minimum Annual PE Ratio = -41.77
Year | PE Ratio | Change |
---|---|---|
2023 | -4.14 | 7.89% |
2022 | -3.84 | -71.74% |
2021 | -13.59 | -52.37% |
2020 | -28.53 | -31.70% |
The current PE Ratio of Caribou Biosciences, Inc. (CRBU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.19
5-year avg
-18.37
10-year avg
-18.37
Caribou Biosciences, Inc.’s PE Ratio is greater than Intellia Therapeutics, Inc. (-2.33), less than Editas Medicine, Inc. (-0.47), greater than CRISPR Therapeutics AG (-14.55), greater than Verve Therapeutics, Inc. (-2.46), greater than Beam Therapeutics Inc. (-16.53), greater than Fate Therapeutics, Inc. (-1.09), greater than Prime Medicine, Inc. (-1.50), greater than Sana Biotechnology, Inc. (-1.34), greater than Adaptive Biotechnologies Corporation (-4.82),
Company | PE Ratio | Market cap |
---|---|---|
-2.33 | $1.23B | |
-0.47 | $99.65M | |
-14.55 | $3.49B | |
-2.46 | $487.66M | |
-16.53 | $2.39B | |
-1.09 | $187.93M | |
-1.50 | $359.38M | |
-1.34 | $389.60M | |
-4.82 | $942.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caribou Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Caribou Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Caribou Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Caribou Biosciences, Inc. (CRBU)?
What is the highest PE Ratio for Caribou Biosciences, Inc. (CRBU)?
What is the 3-year average PE Ratio for Caribou Biosciences, Inc. (CRBU)?
What is the 5-year average PE Ratio for Caribou Biosciences, Inc. (CRBU)?
How does the current PE Ratio for Caribou Biosciences, Inc. (CRBU) compare to its historical average?